GlassScriptPhysician profile
Suzanne D James
NPI 1487187316
$3,323.40
in general payments reported to CMS, 2019-2025
19 companies · $692 in 2025
The $692 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $727 · 2022: $607 · 2023: $641 · 2024: $657 · 2025: $692.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,990.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,989.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Opko Pharmaceuticals, LLC | $1,060.69 | 2021-2025 | Rayaldee |
| Amgen INC. | $414.13 | 2021-2025 | Krystexxa, Tavneos |
| Astrazeneca Pharmaceuticals LP | $332.13 | 2021-2024 | Farxiga |
| Vifor Pharma, INC. | $297.18 | 2022-2025 | Veltassa, Korsuva |
| Boehringer Ingelheim Pharmaceuticals, INC. | $234.13 | 2022-2024 | Jardiance |
| Akebia Therapeutics INC | $181.84 | 2021-2025 | Vafseo, Auryxia |
| Horizon Therapeutics Plc | $136.16 | 2021 | |
| Calliditas Therapeutics US INC. | $128.32 | 2024-2025 | Tarpeyo |
| Daiichi Sankyo INC. | $110.98 | 2021 | |
| Travere Therapeutics, INC. | $89.55 | 2023-2025 | |
| Ardelyx, INC. | $85.25 | 2024 | Xphozah 30 Mg |
| Nxstage Medical, INC. | $82.94 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $47.12 | 2024-2025 | |
| Fresenius USA Marketing, INC. | $33.86 | 2024 | Liberty Select Cycler, Nxstage System One, Velphoro |
| Novartis Pharmaceuticals Corporation | $26.68 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apellis Pharmaceuticals, INC. | $20.18 | 2025 | Empaveli |
| Ani Pharmaceuticals, INC. | $14.88 | 2025 | Purified Cortrophin Gel |
| Glaxosmithkline, LLC. | $13.93 | 2021 | |
| Mallinckrodt Hospital Products INC. | $13.45 | 2024 | Acthar |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne James listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.